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Elderly donor liver grafts are not associated
with a higher incidence of biliary
complications after liver transplantation:
results of a national multicenter study
Westerkamp AC, Korkmaz KS, Bottema JT, Ringers J, Polak WG,
van den Berg A, van Hoek B, Metselaar HJ, Porte RJ. Elderly
donor liver grafts are not associated with a higher incidence of biliary
complications after liver transplantation: results of a national
multicenter study.
Abstract: Background: Liver transplantation with livers grafts from
elderly donors has been associated with a higher risk of biliary
complications. The aim of this study was to examine whether our
national protocol could contribute to a lower incidence of biliary
complications.
Methods: All adult recipients in the Netherlands transplanted with a
liver from an elderly donor (≥65 yrs; n = 68) in the period January 2000–
July 2011 were matched with recipients of a liver from a donor <65 yr
(n = 136). Outcome parameters were 90-d, one-yr, and three-yr patient/
graft survival rates, biliary complications (non-anastomotic stricture,
anastomotic stricture, biliary leakage, and post-transplant cholangitis),
and postoperative hepatic ischemic injury serum markers (AST/ALT).
Results: The median cold ischemia time (CIT) was 7:25 (h:min) in the
group recipients of an elderly donor liver graft. Ninety-day, one-yr, and
three-yr patient/graft survival rates were similar between the group with
an elderly donor liver and their younger controls. Moreover, no
differences were found in the incidence of biliary complications and
postoperative levels of AST/ALT between the two groups.
Conclusion: Transplantation of livers from elderly donors (≥65 yr) is not
associated with a higher incidence of biliary complications, in a national
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One of the main challenges in liver transplantation
(LT) has become the widening gap between donor
organ availability and the number of patients on
the waiting list for LT. One way to decrease the
shortage of liver donor grafts is the use of extended
criteria donor (ECD) livers, which carry a higher
risk of graft failure. Advanced donor age is one of
the criteria to classify a donor liver as ECD liver
(1). Older livers have an impaired regenerative
capacity (2–4) and are subsequently more suscepti-
ble for ischemia/reperfusion (I/R) injury (5–7).
Proposed mechanisms are a decline in liver vol-
ume, impaired response to oxidative stress, dimin-
ished rates of DNA repair, and a reduced
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expression of growth regulatory genes (2, 7).
Donor livers with advanced age (≥65 yr) are there-
fore not widely accepted for LT, especially if other
risk factors are present such as a (expected) pro-
longed cold ischemia time (CIT) (7), donation pro-
cedure after circulatory death (DCD) (8), graft
steatosis (>30% macrovesicular steatosis) (9), and
recipients’ positive hepatitis C virus (HCV) status
(10).
In the Netherlands, the discrepancy between the
number of donor livers and candidates for LT
remains a huge problem, resulting in a 15% mor-
tality rate on the national waiting list in 2013 (11).
The three liver transplant centers in the Nether-
lands, therefore, agreed to consider all potential
donors for liver donation regardless donor age.
Due to this national policy, the average donor age
has increased during the last decade and the per-
centage of elderly donors (≥65 yr) has increased in
parallel with this. Allocation of all donor livers is
based on a patient-oriented system in which prior-
ity is defined by the model for end-stage liver dis-
ease (MELD) score.
Biliary complications, including non-anasto-
motic biliary strictures (NAS), are a major cause of
mortality and morbidity after LT (12). A single-
center report suggested that NAS are more fre-
quent after transplantation of livers from donor
with advanced age, especially when the CIT is
longer than 10 h (13). However, it remains unclear
whether short CITs could contribute to a lower
incidence of NAS when elderly donor livers are
used for LT. Moreover, data about the rate of
other biliary complications, such as biliary leakage
and post-transplant cholangitis after LT with
elderly donors, are not fully known.
We, therefore, conducted a Dutch multicenter
study to examine outcome after transplantation of
liver grafts from elderly donors (≥65 yr). We spe-
cifically focused on the incidence of biliary compli-
cations as NAS, anastomotic strictures (AS),
biliary leakage, and post-transplant cholangitis,
within a national policy ensuring short logistics.
Patients and methods
Study population
In this retrospective study, all adult recipients
undergoing a full-size LT in the period January
2000 till July 2011 were reviewed. All three Dutch
transplant centers (Groningen, Leiden, and Rotter-
dam) participated in this national study. Pediatric
transplants (age < 18 yr), retransplantations, liv-
ing donations, and combined organ transplanta-
tions were excluded. Sixty-eight adult patients with
a primary liver graft derived from a 65-yr or older
donor formed the basis of this study. Of all 68
patients, 29 underwent LT in Groningen, 26 in Rot-
terdam, and 13 patients received a liver graft from
an elderly donor in Leiden. All patients had a mini-
mal follow-up period of two yr, and follow-up was
complete for all patients until the first of June 2013.
Characteristics of the patients, including donor and
recipient variables, as well as surgical factors were
obtained from a prospectively maintained com-
puter database of the Dutch Transplantation Foun-
dation (NOTR). When necessary, the original
patient notes were reviewed for missing informa-
tion. The percentage of missing variables was 3%.
According to national legislation, this type of retro-
spective analysis using anonymous data is allowed
in the Netherlands and does not require informed
consent from the individual patients.
To examine the effect of advanced donor age on
outcome after LT, all recipients receiving a liver
graft ≥65 yr were matched at random in a 1:2 ratio
with control recipients, who received a liver from a
donor below 65 yr in the same time period. To
eliminate any confounding effect of a “center
effect” (14), the matching process was stratified per
transplant center. Matching was based on the fol-
lowing variables: type of donor graft (donation
after brain death [DBD] or DCD), MELD score
(5 points), and recipient age (5 yr). The MELD
score was calculated on the day of LT disregarding
extra points for standard or non-standard
exceptions.
National policy for allocation and transplantation of
elderly donor livers
Donor liver allocation in the Netherlands is
based on a patient-oriented, MELD score-based
system. The three transplant centers share one
national waiting list and donor livers that come
available are first offered to the patient with the
highest MELD score (either based on laboratory
values or exceptional MELD points). This alloca-
tion process is not different for ECD livers; how-
ever, centers are allowed to refuse a potential
high-risk donor liver (i.e., from an elderly donor)
for a specific recipient. Reasons for declining an
ECD liver may include a high recipient MELD
score, positive HCV recipient status, or a large
age difference between donor and recipient. The
refused graft is subsequently offered to the next
recipient on the waiting list. According to the
Dutch national protocol for DCD donors, donor
age above 60 yr is a contraindication for liver
donation, which resulted in a very sparse use of
elderly DCD livers in this study. In general,
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elderly donors are accepted for liver donation
when there are no other major risk factors for
early graft failure such as moderate or severe
steatosis (>30% macrovesicular steatosis), exten-
sive comorbidity in the donor, or a long (>5 d)
intensive care unit (ICU) admission of the donor.
Assessment of graft steatosis in our study con-
sisted of a combination of macroscopic inspec-
tion of the donor liver by the surgeon during
organ procurement and clinical assessment based
on the donor’s medical history, current condition,
and laboratory studies. Frozen section liver
biopsy was not standard part of donor evaluation
in the Eurotransplant area. Additionally, ultraso-
nography or computer tomography scanning was
not routinely performed prior to donation to
evaluate liver steatosis in the donor, as described
previously (15).
All three transplant centers had a general pol-
icy to try to keep the CIT as short as possible.
Generally, the surgical procedure in the recipient
was started as soon as quality aspects of the graft
were discussed with the surgeon performing the
donor procedure. In many cases, the recipient
operation had advanced that far, that the donor
liver could be immediately implanted upon arri-
val after the back table procedure. The preferred
recipient operation was the cava-sparing piggy-
back technique, which resulted in a shorter anas-
tomosis time in comparison with the classical
implantation technique (one vs. two caval anasto-
moses).
Donor and recipient characteristics and surgical
variables
The donor risk index (DRI) was calculated accord-
ing to Feng et al. (16), with minor adjustments for
the Eurotransplant population as described by
Braat et al. (17) (considering all donors Caucasian
and local). In addition, the following donor vari-
ables were collected and included in the analyses:
gender, body mass index (BMI), causes of death,
type of donor (DBD or DCD), and length of stay
in the ICU. Recipient variables collected and
included were as follows: age, gender, year of
transplantation, body mass index (BMI), indica-
tion for transplantation, MELD score, recipient
status on the Eurotransplant waiting list (elective
vs. high urgency), time on the waiting list, length
of stay in the ICU, and the need for retransplanta-
tion. With respect to the surgical variables, the
following parameters were examined: graft implan-
tation technique (conventional vs. piggyback),
CIT, warm ischemia time (WIT), type bile duct
anastomosis, and amount of total blood loss.
Outcome parameters
Primary non-function (PNF) was defined as non-
life-sustaining function of the liver requiring re-
transplantation or leading to death within seven d
after LT. Graft and patient survival rates were
assessed at 90-d, one-yr, and three-yr after LT.
Graft survival was defined as the time period
between LT and patient death or retransplanta-
tion. Patient survival was defined as the time per-
iod between LT and patient death. The period of
90 d after LT was chosen because the most impor-
tant impact of CIT on graft function should be evi-
dent within this time period (7, 16). Bile duct
strictures were classified as either at the site of the
anastomosis (AS) or non-anastomotic strictures
(NAS), as diagnosed by biliary imaging including
endoscopic retrograde cholangiopancreatography,
magnetic resonance imaging, or percutaneous tran-
shepatic cholangiography. Based upon the first
date of presentation, cases of NAS were subdivided
into two groups: early NAS defined as presentation
within one yr and late NAS with presentation after
one yr. Postoperative cholangitis was diagnosed
on clinical symptoms (chills, fever) in combination
with laboratory values indicating cholangitis. For
post-transplant cholangitis, antibiotics were given.
Biliary leakage was always confirmed by biliary
imaging. If necessary, biliary leakage was resolved
by endoscopic treatment or surgical intervention.
Occurrence of hepatic artery thrombosis was diag-
nosed with Doppler ultrasonography (performed
routinely on postoperative day 1, 4, and 7 or more
often when clinically indicated) and was always
confirmed by CT angiography or abdominal explo-
ration. HCV recurrence was determined on the
basis of liver histopathology as reported by an
experienced local pathologist in combination with
clinical, biochemical, and virological findings.
Liver graft I/R injury markers were assessed by
serum levels of aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) on day 1, 3,
and 7 after LT.
Statistical analysis
Categorical variables were presented as numbers
and percentages. Groups were compared using the
Pearson v2 test or Fisher’s exact test if appropriate.
Continuous variables were expressed as medians
with (interquartile) ranges (IQR), and groups were
compared using the Mann–Whitney U-test. Patient
and graft survival was analyzed according to the
Kaplan–Meier method, and differences between
groups were investigated using the log-rank test.
Statistical significance was indicated by p-values of
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<0.05. Statistical analyses were performed using
the statistical software package SPSS version 22.0
(SPSS Inc, Chicago, IL, USA).
Results
Patient characteristics
Recipient, donor, and surgical characteristics of
the study group and their matched controls are
presented in Table 1. As expected, there were no
significant differences for the matching variables
between the study group and the control group
(transplantation center, type of liver graft, MELD
score, and recipient age). The median CIT in the
study group with elderly donors was 7 h and
25 min (IQR 6:23–9:38 h:min). The DRI was sig-
nificantly higher in recipients of elderly donor liver
grafts compared to their controls. However, the
clinical importance of these differences in DRI
score may be not relevant because elderly donors
automatically achieve due to their advanced age
more points for the DRI score compared to youn-
ger donors. Moreover, the cause of donor death
differed among older donors and their controls.
Cerebrovascular causes (e.g., cerebral stroke) of
death were more frequently seen in the elderly
donors. In addition, the donor BMI was signifi-
cantly higher in the study group with elderly
donors in comparison with their younger controls.
For all other variables, no statistically significant
differences were found between the two groups.
The impact of elderly donor age on patient and graft
survival
Ninety-day, one-yr, and three-yr patient and graft
survival rates after LT are presented in Table 2.
The median postoperative follow-up was
58 months (range, 30–90 months). Patient survival
rates were not significantly different between recip-
ients of an elderly donor liver (≥65 yr) and recipi-
ents of a younger graft (<65 yr). In addition, no
significant differences were found in 90-d, one-yr,
and three-yr graft survival between the two groups.
Postoperative outcome and biliary complications
Postoperative outcome and complications are sum-
marized in Table 3. The incidence of PNF in the
group with elderly donors was not statistically sig-
nificantly different from that in the control group
of younger aged donors (3% in the study group vs.
4% in the control group, respectively). Further-
more, there were no significant differences in the
number of retransplantations between the two
groups (7% in the study group vs. 8% in the
control group, respectively). Serum markers of I/R
injury, such as AST and ALT, were also compara-
ble between the two groups in the first postopera-
tive week (Fig. 1).
The overall incidence of biliary complications
was not significantly different between the two
groups (Table 3). The incidence of early NAS (first
presentation less than 1 yr after LT) was 9% in
patients receiving a donor liver ≥65 yrs vs. 11% in
the control group (p = 0.68). The incidence of late
NAS (≥1 yr after LT) was 4% in the study group vs.
8% in the control group (p = 0.48). Additionally,
no significant differences were observed in the inci-
dence of the other biliary complications such as AS,
biliary leakage, and post-transplant cholangitis.
Next, we performed a separate analysis of poten-
tial risk factor for the development of any type of
post-ischemic biliary complication including NAS,
AS, or biliary leakage. Variables included in this
analysis were donor age, CIT, WIT, and type of
biliary anastomosis (duct-to-duct vs. Roux-en-Y
hepaticojejunostomy). None of these variables
appeared to be statistically significantly associated
with the development of a post-ischemic biliary
complication.
Discussion
The intention of this national multicenter study
was to investigate outcome after LT of elderly
donor liver grafts (≥65 yr). In particular, we
focused on the incidence of biliary complications
in recipients of an elderly donor liver. The present
study indicates that the use of donors above 65 yr
may result in biliary complication rates that are
comparable to younger donors (<65 yr). Similarly,
patient and graft survival rates after LT with
elderly donor grafts are not different from their
younger controls.
Several donor risk analyses of US and European
transplant registries have reported that advanced
age is an independent predictor for worse postop-
erative outcome after LT (16–21). Single-center
studies, however, reported that elderly donor livers
can be used for LT with favorable patient/graft
survival rates (22–29). The results of the current
study are consistent with these single-center
reports. Nevertheless, our study is the first to assess
outcome after LT with elderly donor livers in a
national multicenter cohort. Moreover, our study
was performed in a matched case analysis includ-
ing stratification per center. Therefore, the risk
that poor clinical outcomes after LT of elderly
donor livers were compensated for good clinical
outcomes achieved in another center may be
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Table 1. Recipient, donor, and surgical characteristics in patients who received a donor liver from an elderly donor (≥65 yr) vs. control patients
without an elderly donor liver (donor age <65 yr)
Variable
Study group
Donor age ≥65 yr (n = 68)
Control group
Donor age <65 yr (n = 136) p-value
Recipient variables
Median age (yr)a 54 (41–65) 53 (20–68) 0.589
Gender
Male 46 (67%) 76 (56%) 0.106
Female 22 (33%) 60 (44%)
BMI (kg/m2) 26 (23–29) 25 (23–28) 0.456
Indication for transplantation
Post-necrotic cirrhosis 43 (63%) 85 (63%) 0.304
Primary sclerosing cholangitis 11 (16%) 25 (18%)
Primary biliary cirrhosis 2 (3%) 11 (8%)
Metabolic disease 2 (3%) 9 (6%)
Acute fulminant liver failure 2 (3%) 4 (3%)
Miscellaneous 8 (12%) 2 (2%)
MELD score 19 (15–27) 20 (14–25) 0.537
Serum creatinine before LT (lmol/L)b 85 (67–114) 78 (64–105) 0.325
Serum total bilirubin before LT (lmol/L)c 54 (24–96) 58 (32–134) 0.340
INR before LT 1.3 (1.1–1.6) 1.4 (1.2–1.6) 0.885
Status on waiting list
Elective 65 (95%) 129 (95%) 1.000
High urgency 3 (5%) 7 (5%)
Waiting time on list (d) 133 (46–342) 239 (57–419) 0.175
Donor variables
Donor risk index 2.2 (2.1–2.4) 1.6 (1.5–1.9) 0.001
Median age (yr)a 68 (65–86) 46 (18–64) 0.001
Gender
Male 32 (47%) 71 (52%) 0.519
Female 36 (53%) 65 (48%)
BMI (kg/m2) 25.4 (24–28) 24.6 (22–26) 0.017
Type of donor liver
DBD 67 (98%) 134 (98%) 1.000
DCD 1 (2%) 2 (2%)
Cause of donor death
Trauma 34 (50%) 91 (67%) 0.045
Cerebrovascular 32 (47%) 41 (30%)
Other 2 (3%) 4 (3%)
Graft size
Full size 68 (100%) 136 (100%) 1.000
Organ preservation fluid
UW 62 (91%) 114 (84%) 0.290
HTK 6 (9%) 20 (14%)
Other 0 2 (2%)
Surgical variables
Venous anastomosis
Piggyback 63 (93%) 131 (96%) 0.236
Classic 5 (7%) 5 (4%)
Type bile duct anastomosis
Duct to duct 58 (85%) 111 (82%) 0.733
Hepaticojejunostomy 10 (15%) 23 (17%)
Choledochoduodenostomy 0 1 (1%)
Cold ischemia timed (h:min) 7:25 (6:23–9:38) 8:09 (7:07–9:47) 0.027
Warm ischemia timee (h:min) 0:35 (0:25–0:42) 0:37 (0:29–0:48) 0.097
Blood loss (L) 3.6 (2.2–6.0) 3.5 (2.1–6.7) 0.828
Data represent median with interquartile ranges (IQR) for continuous variables or numbers (percentages) for categorical variables.
BMI, body mass index; MELD, model of end-stage liver disease; LT, liver transplantation; INR, international normalized ratio; DBD, donation after brain
death; DCD, donation after circulatory death; UW, University of Wisconsin; HTK, histidine–tryptophane–ketoglutarate.
aData are presented as range.
bNormal <110 lmol/L, to convert the value for creatinine to mg/dL, divide by 88.4.
cNormal 0–17 lmol/L, to convert the value for bilirubin to mg/dL, divide by 17.1.
dTime from in situ flushing of the donor organ until the liver is removed from ice for implantation.
eTime from removal of liver from ice until reperfusion via portal vein, hepatic artery, or both.
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minimized. Furthermore, in our study, several con-
founding factors were excluded due to the fact that
recipients of an elderly donor liver and their con-
trol recipients were matched for MELD score, type
of donation (DBD/DCD), and recipient age. Next
to single-center reports with good postoperative
outcome after LT with elderly donor livers (22–
29), the incidence of other major donor-related risk
factors such as DCD and split liver donation is
minimal in the current series. Likewise, it should
be noticed that these elderly donor liver grafts were
transplanted in relatively stable patients without
high MELD scores and without major risk factors
for postoperative graft failure (e.g. presence of
HCV cirrhosis).
A plausible explanation for excellent postoper-
ative outcomes after LT of elderly donor livers
could be the short CIT obtained in the current
series. The median CIT was 7:25 (h:min) in the
group recipients of an elderly donor liver graft.
In the Netherlands, donor livers are nationally
allocated and due to short travel distances and
parallel surgical procedures, we are able to keep
the CIT short (preferably less than 8 h). In gen-
eral, there may be a threshold at which injury
caused by ischemia and I/R injury becomes irre-
versible and influences substantially postoperative
outcome. With respect to elderly donor livers, it
is known that older-aged livers are more prone
to ischemia and I/R injury (5–7). When elderly
donor livers are used for LT, it is therefore neces-
sary to keep the CIT as short as possible to with-
stand the harmful effects of ischemia and I/R
injury. In our study, recipients of an elderly
donor liver showed postoperative serum levels of
the ischemic injury markers, AST and ALT, simi-
lar to those of their younger controls. Ischemia/
reperfusion injury-related graft failure is mainly
manifest within the first 90 d postoperative (7,
16). In our series, no differences in 90-d graft sur-
vival rates were observed between the group
recipients of an elderly donor liver and the recipi-
ents of a younger donor liver graft.
In our study, we did not find an association
between advanced donor age and biliary complica-
tions such as NAS, AS, biliary leakage, and post-
transplant cholangitis. However, in other retro-
spective studies, a positive relationship between
elderly donor livers and NAS has been reported
(13, 30, 31). Recently, three independent clinical
studies have demonstrated that major epithelial
cell loss in the extrahepatic bile ducts can be seen
in more than 80% of the donor livers (DBD and
DCD) after cold storage (32–34). The observation
that only the minority develops NAS has led to the
hypothesis that proliferation and regeneration of
the bile duct wall, rather than ischemic injury
alone, are important factors in the pathogenesis of
NAS (35). Because of the poorer regeneration
capacity due to the aging process (2–4), we can
assume that elderly donor livers are more susceptible
for the development of NAS. Nevertheless, in the
current study, the incidence of the ischemia-
related type of NAS (NAS presentation within
Table 2. Comparison of patient and graft survival rates in patients
who received an elderly donor (≥65 yr) liver vs. control patients with-
out an elderly donor liver (<65 yr)
Variable
Study group
Donor age ≥65 yr
(n = 68)
Control group





90-d 94 (99–90) 90 (95–86) 0.143
1-yr 90 (95–85) 85 (90–80) 0.526
3-yr 77 (87–68) 77 (84–70) 0.949
Graft survival (%)
90-d 93 (96–89) 87 (89–80) 0.281
1-yr 84 (89–82) 79 (83–74) 0.373
3-yr 75 (85–65) 74 (81–67) 0.791
The value in the parentheses is the 95% confidence interval of the survival
rate.
Table 3. Postoperative outcome parameters in patients who
received a donor liver from an elderly donor (≥65 yr) vs. control




yr (n = 68)
Control group
Donor age <65




Immediate function 66 (97%) 132 (96%) 0.623
Primary
non-function




5 (7%) 12 (8%) 0.117
Biliary complications
Early NAS (<1yr) 6 (9%) 15 (11%) 0.684
Late NAS
(≥1 yr)
3 (4%) 11 (8%) 0.475
Anastomotic stricture 11 (16%) 25 (18%) 0.697
Biliary leakage 8 (12%) 9 (7%) 0.361
Postoperative
cholangitis













Median ICU stay (d) 3 (2–7) 2 (1–5) 0.931
Data represent median with interquartile ranges (IQR) for continuous vari-
ables or numbers (percentages) for categorical variables.
NAS, non-anastomotic stricture; HCV, hepatitis C virus infection; ICU,
intensive care unit.
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1 yr) was not higher in recipients of an elderly
donor liver compared to younger controls. There-
fore, we do not consider advanced donor age as
a major risk factor for the development of NAS
after LT.
By the use of a national protocol for allocation
and LT of elderly donor livers in the Netherlands,
we are able to keep the CIT short. We believe this
is currently the best strategy to deal with donor liv-
ers with advanced donor age. Other techniques to
improve outcome after LT of elderly donor livers
could come from more sophisticated techniques
such as machine preservation. It has been shown
that a short period of oxygenated machine perfu-
sion at the end of the period of static cold storage
under hypothermic conditions (10°C) could lower
the effects of I/R injury and improve functionality
of the graft (36). In addition, with (sub)normother-
mic machine perfusion (perfusion from 20 to
37°C), ex vivo assessment of liver viability prior to
LT could be examined (37). Although machine
perfusion is a very promising method for improve-
ment of graft quality during preservation of ECD
livers, this technique should be studied in clinical
trials. We recently initiated such a trial to examine
the benefitis of hypothermic machine perfusion in
DCD LT.
In conclusion, this national multicenter study
demonstrates that elderly donor livers can be
transplanted with excellent postoperative out-
comes, when a policy is adapted wherein the CIT is
kept as short as possible and recipient and addi-
tional donor-related risk factors are kept to a mini-
mum. Moreover, this study does not confirm an
association between biliary complications (espe-
cially NAS) and elderly donor livers. Therefore, by
the use of strict logistics and eliminating recipient
and additional donor-related risk factors, elderly
donors could be safely used for expanding the
donor pool.
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